CURE6d
First Patent Dosed With Pocenbrodib in Trial for Metastatic Prostate Cancer
First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...
Prostate cancer check doubles proportion of men who keep erectile function
NeuroSafe preserves the nerves running through the prostate’s outer layers, which are thought to be responsible for producing ...
Breakthrough in prostate cancer treatment offers hope for erectile function
The NeuroSafe technique focuses on preserving the delicate nerves that run through the outer layers of the prostate, believed ...
How inherited cancer risks can be used for effective personalized therapy
Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...
Express & Star4d
Prostate cancer check doubles proportion of men who keep erectile function
During cancer surgery, the prostate is removed while the nerves ... be able to access NeuroSafe on the NHS as long as the right pathology support is available. He told the PA news agency ...
News-Medical.Net on MSN1d
Study uncovers protective mechanism of BRCA2 in cancer treatment
Mutations in BRCA2 — a gene known to repair damaged DNA and suppress tumor formation — can predict an individuals' predisposition to develop breast cancer, ovarian, prostate, pancreatic, and other ...
MassDevice3d
Philips, Ibex expand partnership for AI-enabled pathology workflows
Philips announced an expanded partnership with Ibex Medical Analytics and the release of its latest Philips IntelliSite ...
PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting
In addition to its scientific sessions, PathAI will host H&E by the Sea, an AI-powered pathology networking event on March 25 th at 6:00 p.m. ET at the Nautilus Pier 4. The event will bring together ...